FOR INVESTORS

Researchers believe AAGP® could lead to a future where some causes of blindness could be overcome. In recent pre-clinical studies, AAGP® has been shown to successfully prevent ocular inflammation and greatly improve the success rate of retinal cell replacement. These strategies may ultimately restore vision in many cases. These benefits could also be translated to the prescription market for eye conditions and protection.

AAGP® has shown potential to protect and recover skin from ultraviolet (UV) radiation, harsh chemicals and atopic dermatitis, based on laboratory findings. For the millions of individuals who suffer from skin conditions worldwide, AAGP® could have a role to play in helping prevent burns, inflammation, scarring, signs of aging and more.

AAGP® could help to improve transplant success rates through increased cell survival by reducing or eliminating cell stress and inflammation caused by transplantation. In a laboratory setting, it has been shown to successfully protect various cell types used in regenerative medicine and has potential to benefit whole organ transplantation.

AAGP® helps to preserve cell viability during cryostorage and biologic production. It could increase production yields of therapeutic antibodies used in immunotherapy treatments for cancer, autoimmune diseases, infections and other disorders. This could make biologics more accessible to the world.